Fairman Jeff 4
4 · Vaxcyte, Inc. · Filed Aug 5, 2022
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-08-04$25.50/sh−10,000$255,000→ 311,227 total(indirect: By Trust) - Sale
Common Stock
2022-08-05$25.70/sh−5,000$128,508→ 306,227 total(indirect: By Trust)
Holdings
- 17,662
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $26.035. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.